Sartorius Cell Therapy Product Characterization Services

Source: Sartorius

Cell therapy products like mesenchymal stem cells and cellular immunotherapies such as Chimeric Antigen Receptor T cells (CAR-T) face the regulatory challenge of meeting rigorous standards for safety and characterization. In autologous therapy programs, the timeline between product manufacture and release is short and rapid testing solutions are required.

Sartorius Stedim North America cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online